| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/19/2011 | EP2274011A2 An antibody bound synthetic vesicle containing active agent molecules |
| 01/19/2011 | EP2274010A1 Therapeutic combinations of anti-igf-1r antibodies and other compounds |
| 01/19/2011 | EP2274009A2 Methods of treatment |
| 01/19/2011 | EP2274008A2 Compositions and methods for inhibiting pdgfrbeta and vegf-a |
| 01/19/2011 | EP2274007A2 Modulation of blood brain barrier permeability |
| 01/19/2011 | EP2274001A2 Heat shock protein gp96 vaccination and methods of using same |
| 01/19/2011 | EP2273986A2 Encapsulation of biologically active agents |
| 01/19/2011 | EP1693456B1 Method of identifying modulators of a g protein-coupled receptor |
| 01/19/2011 | EP1668036B1 Method for the production of human antibodies blocking the biological activity of a human cytokine |
| 01/19/2011 | EP1660121B1 Live attenuated bacterial vaccine |
| 01/19/2011 | EP1644501B1 Ssx-2 peptides presented by hla class ii molucules |
| 01/19/2011 | EP1606391B1 Virulent systemic feline calicivirus |
| 01/19/2011 | EP1600507B1 Mutant SREBP-1c promoters and use thereof |
| 01/19/2011 | EP1556071B1 Methods to prevent tumor recurrence by blockade of tgf-beta |
| 01/19/2011 | EP1423419B1 Hybrid and tandem expression of neisserial proteins |
| 01/19/2011 | EP1411962B1 Monoclonal antibody therapy for pancreas cancer |
| 01/19/2011 | EP1252300B1 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
| 01/19/2011 | EP1185296B1 Prevention and treatment of amyloidogenic diseases |
| 01/19/2011 | CN1809633B Recombinant influenza viruses holding a mutation in a transmembrane protein gene |
| 01/19/2011 | CN101952429A STAT3 epitope peptides |
| 01/19/2011 | CN101952427A Novel constructs for expression of influenza virus |
| 01/19/2011 | CN101952426A Anti-BST2 antibody |
| 01/19/2011 | CN101952414A Agents that engage antigen - presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR) |
| 01/19/2011 | CN101952321A Recombinant RSV antigens |
| 01/19/2011 | CN101952320A Material with immunogenicity |
| 01/19/2011 | CN101952319A Anti-mesothelin antibodies and uses therefor |
| 01/19/2011 | CN101952318A Anti-NR10 antibody, and use thereof |
| 01/19/2011 | CN101952313A 14-3-3 eta antibodies and uses thereof for the diagnosis and treatment of arthritis |
| 01/19/2011 | CN101952311A G immunoglobulin used against anthrax toxins |
| 01/19/2011 | CN101951955A Pharmaceutical composition for cancer treatment |
| 01/19/2011 | CN101951954A Molecules and methods for modulating low-density-lipoprotein receptor-related protein 6 (LRP6) |
| 01/19/2011 | CN101951953A Pharmaceutical composition comprising anti-GRP78 antibody as active ingredient |
| 01/19/2011 | CN101951952A Immunotherapeutic method for increasing groundnut tolerance in a subject |
| 01/19/2011 | CN101951951A Chloroplast-derived human vaccine antigens against malaria |
| 01/19/2011 | CN101951950A Vaccine |
| 01/19/2011 | CN101951949A Meningococcal vaccine formulations |
| 01/19/2011 | CN101951948A Methods and compositions related to immunizing against staphylococcal lung diseases and conditions |
| 01/19/2011 | CN101951947A Vaccines for malaria |
| 01/19/2011 | CN101951946A Human antibodies that bind mesothelin, and uses thereof |
| 01/19/2011 | CN101951940A Treatment of autoimmune disorders |
| 01/19/2011 | CN101951931A Immunomodulating compositions and uses therefor |
| 01/19/2011 | CN101948851A Duck-origin coronavirus N protein gene, clone method and application thereof |
| 01/19/2011 | CN101948850A Preparation method and application of virus-like particles of dengue viruses |
| 01/19/2011 | CN101948849A Preparation and use of truncated Cap protein of porcine circovirus type 2 |
| 01/19/2011 | CN101948841A Epitope sequences |
| 01/19/2011 | CN101948836A Schistosoma japonicum zinc finger protein coding gene SjZFP1 and application thereof |
| 01/19/2011 | CN101948816A Vaccine against mumps containing a JERYL-LYNN virus strain |
| 01/19/2011 | CN101948812A Eosinophilic kidney type avian infectious bronchitis virus (IBV) virulent vaccine strain and application thereof |
| 01/19/2011 | CN101948811A Method for expanding antigen spectrum of foot-and-mouth disease vaccine strain by reverse genetic operation and preparation method of vaccine |
| 01/19/2011 | CN101948809A Inactivated vaccine for preventing duck viral hepatitis and preparation method thereof |
| 01/19/2011 | CN101948792A O157:H7 enhancement mucosal immunity multivalence fusion type recombination strain and vaccine |
| 01/19/2011 | CN101948791A Marker-free gene deletion attenuated mutant of vibrio alginolyticus wild strain, related preparation and application |
| 01/19/2011 | CN101948546A Fusion protein SAmB as well as coding gene and applications thereof |
| 01/19/2011 | CN101948540A Preparation of novel anti-EGFR human source antibody MIL27 and application thereof |
| 01/19/2011 | CN101948539A IL-18 binding proteins |
| 01/19/2011 | CN101948536A Porcine transmissible gastroenteritis virus (PTGEV) and porcine epidemic diarrhea virus (PEDV) dual yolk antibody and preparation method thereof |
| 01/19/2011 | CN101948527A Mature peptide of fish somatostatin and application thereof |
| 01/19/2011 | CN101948516A Establishment and application of vaccinia virus vector-based reverse genetics system |
| 01/19/2011 | CN101948510A Molecular mimic peptide of type O foot and mouth disease virus VP2 epitope and applications thereof |
| 01/19/2011 | CN101948508A Tumor-resistance CTL (Cytotoxic T Lymphocyte) epitope peptide derived from PIWIL2 and application thereof |
| 01/19/2011 | CN101947325A Vibrio paraheamolyticus bivalent DNA vaccine as well as preparation method and application thereof |
| 01/19/2011 | CN101947323A Gram negative bacterium vaccine and preparation method thereof |
| 01/19/2011 | CN101947321A Heat-resisting and freeze-drying protector for live vaccine and preparation method thereof as well as live newcastle disease vaccine |
| 01/19/2011 | CN101947318A Method for preparing porcine parvovirus inactivated vaccines |
| 01/19/2011 | CN101947317A Large-scale preparation method of H5N1 avian influenza virus-like particle vaccines |
| 01/19/2011 | CN101947316A Subunit mixed vaccine of human enterovirus 71 |
| 01/19/2011 | CN101947306A Treatment of T-cell mediated diseases |
| 01/19/2011 | CN101946746A Food therapy method for reducing morbidity rate of hand-foot-and-mouth disease and reducing incidence of severe symptoms |
| 01/19/2011 | CN101575586B Bordetella bronchiseptica gene deleted vaccine and application |
| 01/19/2011 | CN101298471B Epitope capable of exciting human body anti-mycobacterium tuberculosis protective immunity reaction and use thereof |
| 01/19/2011 | CN101156952B DC cell targeted carrier, nanometer corpuscle and preparation method |
| 01/18/2011 | US7872114 Or Escherichia coli (E. coli) heat labile toxin where in the amino acid sequence, serine-63 and arginine-192 are replaced by another amino acid; vaccines against cholera and enterotoxigenic strain of E. coli |
| 01/18/2011 | US7872110 Deimmunized monoclonal antibodies for protection against HIV exposure and treatment of HIV infection |
| 01/18/2011 | US7872102 Anti-IL-23 antibodies |
| 01/18/2011 | US7871986 provides a prostate specific antigen oligo-epitope peptide (PSA-OP) that is useful as an immunogen in the prevention or treatment of prostatic cancer and in the inhibition of prostatic cancer cells and in the establishment and characterization of PSA-specific cytotoxic T-cell lines |
| 01/18/2011 | US7871816 for preparing a vaccine which contains one or more than two genes among pgs B, pgs C and pgs A encoding poly- gamma -glutamate synthetase complex and genes selected from human papilloma virus (HPV) E6 and HPV E7 antigen protein associated with tumor induction; genital wash |
| 01/18/2011 | US7871814 Recombinant bicistronic flaviviruses and methods of use thereof |
| 01/18/2011 | US7871807 under any circumstances, in a short period of time and in large amount; vaccine; immunizing a hen by administering a flu vaccine to hen to trigger embryogenesis in its eggs, infecting the embryonated eggs by inoculating a flu virus into the allantoic cavity, incubating, harvesting the allantoic fluid |
| 01/18/2011 | US7871798 Mammalian cells that express VEGF-D polypeptides |
| 01/18/2011 | US7871786 Isolated nucleic acid encoding GEF-H1b polypeptide (Guanine nucleotide exchange factors); diagnosing abnormal cell proliferation and drug screening; measuring phosphorylation by p-21 activated kinase; antitumor agents, anticancer agents |
| 01/18/2011 | US7871782 Synaptic vesicle glycoprotein specific immunoglobulin for use in treatment and prevention of liver disorders; tissue targeted therapy |
| 01/18/2011 | US7871767 Polymorphisms in the human gene for cytochrome P450 polypeptide 2C8 and their use in diagnostic applications |
| 01/18/2011 | US7871765 Composition having antitumor effect |
| 01/18/2011 | US7871631 Inhibit inflammation for long periods without accompanying serious side effects in the drug therapy to patients with inflammatory bowel syndrome |
| 01/18/2011 | US7871630 Locally administering to tumor antigen-releasing agent, tumor leukocyte attractant and tumor interferon-gamma (IFN-g), and second type 1 inflammatory response-(IR1-)promoting agent for tumor therapy |
| 01/18/2011 | US7871629 immunizing fish against bacterial and viral infection by immersing the fish in a solution comprised of an effective amount of dead or attenuated, whole-celled recombinant bacteria, the recombinant bacteria having a eukaryotic expression vector (plasmid) incorporated therein having DNA of interest |
| 01/18/2011 | US7871628 Peptide mimics of conserved gonococcal epitopes and methods and compositions using them |
| 01/18/2011 | US7871627 Gram positive bacteria preparations for the treatment of disease comprising an immune dysregulation |
| 01/18/2011 | US7871626 Modified influenza virus for monitoring and improving vaccine efficiency |
| 01/18/2011 | US7871625 hepatitis C virus (HCV); immunoassay; recombinant vectors, host cells; kits |
| 01/18/2011 | US7871624 fusion proteins; lysosomal storage diseases; immunoglobulins, mucopolysaccharides; for treating fetus or embryo |
| 01/18/2011 | US7871623 administering imaging composition comprising labeled annexin coupled to biocompatible radionuclide such as Technetium 99 |
| 01/18/2011 | US7871622 Stably tethered structures of defined compositions with multiple functions or binding specificities |
| 01/18/2011 | US7871621 Anti-HBs monoclonal antibody |
| 01/18/2011 | US7871620 Immunoliposomes that optimize internationalization into target cells |
| 01/18/2011 | US7871619 Using orphan receptors expressed on cell surfaces as screening tool in identifying modulating agents of cell proliferation; antitumor agents |
| 01/18/2011 | US7871618 Contact dermatitis, Drug induced delayed type cutaneous allergic reactions, Toxic epidermal necrolysis, Cutaneous T cell Lymphoma, Bullous pemphigoid, Alopecia aereata, Vitiligo, Acne Rosacea, Prurigo nodularis, Scleroderma, Herpes simplex virus; conjugated to polyoxyethylene glycol, serum albumin |
| 01/18/2011 | US7871617 Von Willebrand's factor (VWC); transforming growth factors, bone morphongenic proteins as cofactors; monoclonal antibodies for use in diagnosis and treatment of diabetes, hypertension, hyperglycemia and congestive heart failure |
| 01/18/2011 | US7871616 Anti-IL-22RA antibodies and binding partners and methods of using in inflammation |
| 01/18/2011 | US7871614 Gold-binding protein and use thereof |